ALP Bio
PrivateLast Round
Series B
Jul 22, 2021
Total Funding Raised
$100M
Company Overview
ALP Bio is a biotechnology company that develops a novel class of macrocyclic peptides that enhance cellular autophagy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ALP Bio Comparables
Compare ALP Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Parallel Bio | 81% | |
| EpiVax | 74% | |
| Certara | 72% |
ALP Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 22, 2021 | ||||
| Series A | Jan 1, 2019 |
ALP Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A, Series B |
| Hillhouse Investment | Series B |
| Germin8 Ventures | Series B, Series A |
| FootPrint Coalition | Series B |
| Breakthrough Energy Ventures | Series B |
| Pear VC | Seed, Series B, Series A |
| Y Combinator | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 22, 2021
$75M round led by Andreessen Horowitz and Breakthrough Energy Ventures.
- Jan 1, 2019
$25M round with participation from Andreessen Horowitz and AgFunder.
ALP Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ALP Bio's valuation, stock price, and market status.
Is ALP Bio a public or private company?
ALP Bio is a private company.
What is the current stock price of ALP Bio?
ALP Bio is a private company with no public stock price. No recent secondary market data is available.
How much is ALP Bio worth (valuation)?
Valuation information for ALP Bio is not publicly available.
Can I buy ALP Bio stock?
ALP Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ALP Bio's last funding round?
ALP Bio's most recent funding round was Series B on July 22, 2021.
Who are the main investors in ALP Bio?
Key investors in ALP Bio include Andreessen Horowitz, Breakthrough Energy Ventures.
Will ALP Bio IPO soon?
No public IPO plans have been announced for ALP Bio.
How can I track ALP Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ALP Bio's secondary market activity and sign up for updates.